Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

TLA Targeted Immuno Therapies AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 452 More Arrow 1,885 Less Arrow 1,772
Financial expenses 1,252 Less Arrow 772 Less Arrow 653
Earnings before taxes -10,913 More Arrow -8,701 More Arrow -6,185
EBITDA -6,382 More Arrow -5,449 More Arrow -4,781
Total assets 30,068 Less Arrow 28,234 More Arrow 28,933
Current assets 4,864 More Arrow 5,626 More Arrow 6,489
Current liabilities 40,104 Less Arrow 23,638 Less Arrow 15,979
Equity capital -22,451 More Arrow -10,774 More Arrow -2,137
- share capital 265 Less Arrow 248 More Arrow 256
Employees (average) 4 Equal arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -74.7% More Arrow -38.2% More Arrow -7.4%
Turnover per employee 113 More Arrow 471 Less Arrow 443
Profit as a percentage of turnover -2414.4% More Arrow -461.6% More Arrow -349.0%
Return on assets (ROA) -32.1% More Arrow -28.1% More Arrow -19.1%
Current ratio 12.1% More Arrow 23.8% More Arrow 40.6%
Return on equity (ROE) 48.6% More Arrow 80.8% More Arrow 289.4%
Change turnover -1,567 More Arrow 166 Less Arrow -13,800
Change turnover % -78% More Arrow 10% Less Arrow -89%
Chg. No. of employees 0 Equal arrow 0 Less Arrow -2
Chg. No. of employees % 0% Equal arrow 0% Less Arrow -33%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.